New glucose monitor aims to prevent dangerous low blood sugar in kids

NCT ID NCT04959552

Ongoing Disease control Sponsor: Abbott Diabetes Care Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing the safety of the FreeStyle Libre 2, a device that continuously checks blood sugar levels, in 550 children and young adults aged 4 to 30 with type 1 or type 2 diabetes. The goal is to see if using this monitor reduces severe low blood sugar events that need medical help, compared to standard finger-prick testing. Participants wear the sensor and continue their usual diabetes care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETE MELLITUS

Contacts and locations

Locations

The Children's Mercy Hospital

Kansas City, Missouri, 64108, United States
The DOCS

Las Vegas, Nevada, 89113, United States
Yale Pediatric Endocrinology Clinic

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.